More US patients receive multiple psychotropic medications

January 4, 2010, JAMA and Archives Journals

An increasing number of U.S. adults are being prescribed combinations of antidepressants and antipsychotic medications, according to a report in the January issue of Archives of General Psychiatry.

In some clinical situations, evidence suggests that more than one psychotropic (affecting the brain or mind) medication may be beneficial, according to background information in the article. For instance, a patient with depression who does not respond to one medication alone might require a second antidepressant, or an individual who has depression with psychotic features might respond to a combination of an antidepressant and an antipsychotic. "In routine psychiatric practice, however, patients often receive psychiatric medication combinations that are not well supported by controlled clinical trials," the authors write.

To examine patterns and trends in psychotropic polypharmacy—or the prescription of more than one psychiatric medication—Ramin Mojtabai, M.D., Ph.D., M.P.H., of Bloomberg School of Public Health, Johns Hopkins University, Baltimore, and Mark Olfson, M.D., M.P.H., of Columbia University Medical Center and the New York State Psychiatric Institute, New York, analyzed data collected from a national sample of office-based psychiatry practices. The number of medications prescribed and specific medication combinations were assessed from a total of 13,079 office visits to psychiatrists by adults (18 years or older) between 1996 and 2006.

Overall, there was an increase in the number of psychotropic medications prescribed during office visits. Between 1996 to 1997 and 2005 to 2006, the percentage of visits at which two or more medications were prescribed increased from 42.6 percent to 59.8 percent and the percentage of visits at which three or more medications were prescribed increased from 16.9 percent to 33.2 percent. In addition, the median (midpoint) number of medications prescribed at each visit increased from one to two (an average increase of 40.1 percent).

"The increasing trend of psychotropic polypharmacy was mostly similar across visits by different patient groups and persisted after controlling for background characteristics," the authors write. Combinations of with sedative-hypnotics were the most common medication combinations overall (23.1 percent), followed by combinations of antidepressants with antipsychotics (12.9 percent) and combinations of two types of antidepressants (12.6 percent).

"While the evidence for added benefit of antipsychotic polypharmacy is limited, there is growing evidence regarding the increased adverse effects associated with such combinations," the authors write. For example, some combinations have resulted in increases in body weight and total cholesterol level, whereas others may be associated with an increase in fasting blood glucose level.

"Because scant data exist to support the efficacy of some of the most common medication combinations, such as antipsychotic combinations or combinations of antidepressants and antipsychotics, prudence suggests that renewed clinical efforts should be made to limit the use of these combinations to clearly justifiable circumstances," the authors conclude. "At the same time, a new generation of research is needed to assess the efficacy, effectiveness and safety of common concomitant medication regimens, especially in patients with multiple disorders or monotherapy-refractory conditions."

More information: Arch Gen Psychiatry. 2010;67[1]:26-36

Related Stories

Recommended for you

Study with infants suggests language not necessary for reasoning ability

March 16, 2018
A team of researchers from Spain, Hungary and Poland has found via a study with infants that language may not be a necessity for the ability to reason. In their paper published in the journal Science, the group describes ...

Hep C compounds alcoholism's effect on brain volume

March 16, 2018
(HealthDay)—Alcohol dependence has deleterious effects on frontal cortical volumes that are compounded by hepatitis C virus (HCV) infection and drug dependence, according to a study published online March 14 in JAMA Psychiatry.

Older adults' difficulties with focusing can be used to help put a face to a name

March 16, 2018
Everyone has experienced the awkward situation of meeting someone and then forgetting their name shortly after. Among older adults, this happens more often than not.

Study casts doubt on ketamine nasal sprays for depression

March 16, 2018
Researchers from the Black Dog Institute and UNSW Sydney have questioned the efficacy and safety of intranasal ketamine for depression, with their pilot trial stopped early due to poor side effects in patients.

A little anger in negotiation pays

March 16, 2018
During negotiations, high-intensity anger elicits smaller concessions than moderate-intensity anger, according to a new study by management and business experts at Rice University and Northwestern University.

Research reveals brain mechanism involved in language learning

March 15, 2018
Learning a new language may be more of a science than an art, a University of Sussex study finds.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.